162 related articles for article (PubMed ID: 23848176)
1. Treatment of melasma with oral administration of compound tranexamic acid: a preliminary clinical trial.
Li Y; Sun Q; He Z; Fu L; He C; Yan Y
J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):393-4. PubMed ID: 23848176
[No Abstract] [Full Text] [Related]
2. Oral tranexamic acid for the treatment of melasma.
Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
[TBL] [Abstract][Full Text] [Related]
3. Oral tranexamic acid for the treatment of melasma.
Ali FR
Clin Exp Dermatol; 2019 Apr; 44(3):347-349. PubMed ID: 30484898
[No Abstract] [Full Text] [Related]
4. Oral tranexamic acid lightens refractory melasma.
Tan AWM; Sen P; Chua SH; Goh BK
Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
[TBL] [Abstract][Full Text] [Related]
5. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation.
Na JI; Choi SY; Yang SH; Choi HR; Kang HY; Park KC
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1035-9. PubMed ID: 22329442
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral tranexamic acid on erythema index in patients with melasma.
Nguyen J; Rajgopal Bala H; Ross A; Wong CC; Paul E; Rodrigues M
Australas J Dermatol; 2021 May; 62(2):206-209. PubMed ID: 33125702
[TBL] [Abstract][Full Text] [Related]
7. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
[TBL] [Abstract][Full Text] [Related]
8. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser.
Cho HH; Choi M; Cho S; Lee JH
J Dermatolog Treat; 2013 Aug; 24(4):292-6. PubMed ID: 22103770
[TBL] [Abstract][Full Text] [Related]
9. Treatment of melasma using tranexamic acid: what's known and what's next.
Sheu SL
Cutis; 2018 Feb; 101(2):E7-E8. PubMed ID: 29554171
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid: an important adjuvant in the treatment of melasma.
Tse TW; Hui E
J Cosmet Dermatol; 2013 Mar; 12(1):57-66. PubMed ID: 23438143
[TBL] [Abstract][Full Text] [Related]
11. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
[TBL] [Abstract][Full Text] [Related]
12. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.
Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T
Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional report on melasma among Hispanic patients: Evaluating the role of oral tranexamic acid versus oral tranexamic acid plus hydroquinone.
Arreola Jauregui IE; Huerta Rivera G; Soria Orozco M; Meyer-Nava S; Paniagua Santos JE; López Zaldo JB; Meyer-Nava I; Madrid Carrillo C; Zaldo Rolón IE; Baeza Echeverría AE; Vázquez Huerta M
J Am Acad Dermatol; 2020 Nov; 83(5):1457-1458. PubMed ID: 32151632
[No Abstract] [Full Text] [Related]
14. Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study.
Zhu CY; Li Y; Sun QN; Takada A; Kawada A
Eur J Dermatol; 2019 Feb; 29(1):55-58. PubMed ID: 30734717
[TBL] [Abstract][Full Text] [Related]
15. Systemic treatments for melasma: adjuvant therapy with a novel topical agent.
Cohen PR
Int J Dermatol; 2018 Mar; 57(3):e20-e21. PubMed ID: 29313951
[No Abstract] [Full Text] [Related]
16. The efficacy of tranexamic acid in the treatment of melasma.
Bagherani N
Dermatol Ther; 2015; 28(4):265. PubMed ID: 25649261
[No Abstract] [Full Text] [Related]
17. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study.
Sharma R; Mahajan VK; Mehta KS; Chauhan PS; Rawat R; Shiny TN
Clin Exp Dermatol; 2017 Oct; 42(7):728-734. PubMed ID: 28649780
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies.
Taraz M; Niknam S; Ehsani AH
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133910
[TBL] [Abstract][Full Text] [Related]
19. Oral Tranexamic Acid for the Treatment of Melasma: A Review.
Bala HR; Lee S; Wong C; Pandya AG; Rodrigues M
Dermatol Surg; 2018 Jun; 44(6):814-825. PubMed ID: 29677015
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of oral tranexemic acid in refractory melasma: A clinico-immuno-histopathological study.
Nagaraju D; Bhattacharjee R; Vinay K; Saikia UN; Parsad D; Kumaran MS
Dermatol Ther; 2018 Sep; 31(5):e12704. PubMed ID: 30253023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
